Illumina Urges Fed. Circ. To Reinstate Sequencing Patent
An Illumina Inc. unit pressed the Federal Circuit on Monday to restore a DNA sequencing patent invalidated by the Patent Trial and Appeal Board, saying the patent's sequencing method used a...To view the full article, register now.
Already a subscriber? Click here to view full article